176 related articles for article (PubMed ID: 24878926)
21. Juvenile dermatomyositis.
Batthish M; Feldman BM
Curr Rheumatol Rep; 2011 Jun; 13(3):216-24. PubMed ID: 21312074
[TBL] [Abstract][Full Text] [Related]
22. Juvenile dermatomyositis: clinical profile and disease course in 25 patients.
Shehata R; al-Mayouf S; al-Dalaan A; al-Mazaid A; al-Balaa S; Bahabri S
Clin Exp Rheumatol; 1999; 17(1):115-8. PubMed ID: 10084045
[TBL] [Abstract][Full Text] [Related]
23. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.
Huber AM; Lang B; LeBlanc CM; Birdi N; Bolaria RK; Malleson P; MacNeil I; Momy JA; Avery G; Feldman BM
Arthritis Rheum; 2000 Mar; 43(3):541-9. PubMed ID: 10728746
[TBL] [Abstract][Full Text] [Related]
24. Skin disease is more recalcitrant than muscle disease: A long-term prospective study of 184 children with juvenile dermatomyositis.
Wang A; Morgan GA; Paller AS; Pachman LM
J Am Acad Dermatol; 2021 Jun; 84(6):1610-1618. PubMed ID: 33359787
[TBL] [Abstract][Full Text] [Related]
25. Dermatomyositis in two siblings and a brief review of familial dermatomyositis.
Tsao CY; Mendell JR; Kissel JT
J Child Neurol; 2002 Jul; 17(7):540-2. PubMed ID: 12269736
[TBL] [Abstract][Full Text] [Related]
26. Disease patterns of juvenile dermatomyositis from Western India.
Chickermane PR; Mankad D; Khubchandani RP
Indian Pediatr; 2013 Oct; 50(10):961-3. PubMed ID: 23798628
[TBL] [Abstract][Full Text] [Related]
27. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis.
Constantin T; Ponyi A; Orbán I; Molnár K; Dérfalvi B; Dicso F; Kálovics T; Müller J; Garami M; Sallai A; Balogh Z; Szalai Z; Fekete G; Dankó K
Autoimmunity; 2006 May; 39(3):223-32. PubMed ID: 16769656
[TBL] [Abstract][Full Text] [Related]
28. Current management of juvenile dermatomyositis in Germany and Austria: an online survey of pediatric rheumatologists and pediatric neurologists.
Hinze CH; Speth F; Oommen PT; Haas JP
Pediatr Rheumatol Online J; 2018 Jun; 16(1):38. PubMed ID: 29925381
[TBL] [Abstract][Full Text] [Related]
29. Clinical Characteristics and Course of Patients with Juvenile Dermatomyositis - Case Series.
Rajarathinam I; Raghuram J; Rao AP
Neurol India; 2022; 70(1):300-303. PubMed ID: 35263900
[TBL] [Abstract][Full Text] [Related]
30. [Clinical characteristics of juvenile dermatomyositis complicated with interstitial lung disease].
Chen L; Hu Y; Yao Y; Zhen XF; Chen F; He Q; Mo X; Ma SC
Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):465-9. PubMed ID: 22931947
[TBL] [Abstract][Full Text] [Related]
31. Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment.
Kim S; El-Hallak M; Dedeoglu F; Zurakowski D; Fuhlbrigge RC; Sundel RP
Arthritis Rheum; 2009 Jun; 60(6):1825-1830. PubMed ID: 19479872
[TBL] [Abstract][Full Text] [Related]
32. Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.
Wu JQ; Lu MP; Reed AM
World J Pediatr; 2020 Feb; 16(1):31-43. PubMed ID: 31556011
[TBL] [Abstract][Full Text] [Related]
33. Outcome in juvenile dermatomyositis.
Chowdhary V; Wakhlu A; Agarwal A; Misra R
Indian Pediatr; 2002 Oct; 39(10):931-5. PubMed ID: 12428038
[TBL] [Abstract][Full Text] [Related]
34. Clinical analysis and outcome of interstitial lung disease complicated with juvenile dermatomyositis and juvenile polymyositis.
Sato S; Uejima Y; Nanbu M; Suganuma E; Takano T; Tanaka R; Kabuki T; Oguma E; Oh-Ishi T; Kawano Y
Mod Rheumatol; 2017 Jul; 27(4):652-656. PubMed ID: 27588444
[TBL] [Abstract][Full Text] [Related]
35. Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania.
Furia FF; Godfrey E; Mwamanenge N; Swai P
Pediatr Rheumatol Online J; 2020 Apr; 18(1):30. PubMed ID: 32245494
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome in children with juvenile dermatomyositis: A single-center study from north India.
Sharma A; Gupta A; Rawat A; Suri D; Singh S
Int J Rheum Dis; 2020 Mar; 23(3):392-396. PubMed ID: 31793219
[TBL] [Abstract][Full Text] [Related]
37. The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.
Giancane G; Lavarello C; Pistorio A; Oliveira SK; Zulian F; Cuttica R; Fischbach M; Magnusson B; Pastore S; Marini R; Martino S; Pagnier A; Soler C; Staņēvicha V; Ten Cate R; Uziel Y; Vojinovic J; Fueri E; Ravelli A; Martini A; Ruperto N;
Pediatr Rheumatol Online J; 2019 May; 17(1):24. PubMed ID: 31118099
[TBL] [Abstract][Full Text] [Related]
38. [Juvenile dermatomyositis: A series of 22 cases].
Moegle C; Lipsker D
Ann Dermatol Venereol; 2020 Sep; 147(8-9):494-503. PubMed ID: 32532518
[TBL] [Abstract][Full Text] [Related]
39. [Polymyositis and dermatomyositis in childhood].
Rodríguez Núñez A; Fernández Bustillo JM; Rodríguez Pérez E; Novo Rodríguez I; Pérez Becerra E; Peña Guitián J; Castro Gago M
An Esp Pediatr; 1988 Oct; 29(4):288-92. PubMed ID: 3069018
[TBL] [Abstract][Full Text] [Related]
40. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr.
McCann LJ; Juggins AD; Maillard SM; Wedderburn LR; Davidson JE; Murray KJ; Pilkington CA;
Rheumatology (Oxford); 2006 Oct; 45(10):1255-60. PubMed ID: 16567354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]